Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication

Diana Lindner1, Jia Li2, Konstantinos Savvatis3

  • 1Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany ; German Center for Cardiovascular Research (DZHK), Partner Sites, Hamburg/Kiel/Lübeck, Germany.

Mediators of Inflammation
|November 7, 2014
PubMed

Insights

Cardiac fibroblasts significantly contribute to viral replication in Coxsackievirus B3-induced myocarditis. These cells, alongside cardiomyocytes, are key players in viral load increase and disease severity.

Area of Science:

  • Cardiovascular Biology
  • Virology
  • Immunology

Background:

  • Myocarditis is a severe cardiac inflammation often caused by viral infections.
  • Leukocyte infiltration into cardiac tissue contributes to myocyte loss and cardiac remodeling.
  • Understanding viral replication sources within the heart is crucial for myocarditis pathology.

Purpose of the Study:

  • To investigate cardiac fibroblasts, cardiomyocytes, and macrophages as potential sources of viral replication in Coxsackievirus B3 (CVB3) infection.
  • To determine the role of cardiac fibroblasts in the pathogenesis of CVB3-induced myocarditis.

Main Methods:

  • Infection of C57BL/6j mice with Coxsackievirus B3 (CVB3).
  • Analysis of cytokine gene expression (TNF-α, IL-6, MCP-1, IFN-β) in cardiac cells.
  • Quantification of viral replication in cardiac fibroblasts, cardiomyocytes, and macrophages post-infection.

Main Results:

  • Cardiac fibroblasts showed significantly increased expression of inflammatory and antiviral cytokines compared to cardiomyocytes and macrophages.
  • Cardiac fibroblasts exhibited a 132-fold higher CVB3 replication rate than cardiomyocytes (14-fold increase) between 6 and 24 hours post-infection.
  • Macrophages reduced viral copy numbers at high concentrations, while low concentrations led to persistent infection.

Conclusions:

  • Cardiac fibroblasts are a significant source of viral replication in CVB3-induced myocarditis.
  • Fibroblast involvement exacerbates myocarditis pathology and viral load.
  • Targeting cardiac fibroblasts may offer a therapeutic strategy for viral myocarditis.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
332
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
633
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
473
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
943
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
371